61st Clinical Conference in Pediatric Anesthesiology
February 3 - 5, 2023

Jerrold Lerman MD FRCPC FANZCA
Clinical Professor of Anesthesiology
John R. Oishei Children's Hospital
Buffalo NY 


After graduating with a degree in Chemical Engineering, Dr. Lerman attended medical school at the University of Toronto and completed his anesthesia residency at University of Toronto. After a research fellowship in pediatric anesthesia with Drs. George Gregory and Edmond Eger II at CVRI in San Francisco, he joined the staff at the Hospital for Sick Children in 1983. He became Anaesthetist-in-Chief in 1991 and Professor of Anesthesia at University of Toronto in 1996. In 2002, he joined Great Lakes Anesthesiology in Buffalo, New York, where he currently works. During his 38 year career, Dr. Lerman has served on multiple editorial boards including Anesthesiology, Pediatric Anesthesia, Journal of Anesthesia and Canadian Journal of Anesthesia as well numerous committees. He has received many honours, most notably an honorary Fellowship in the Australia and New Zealand College of Anaesthetists in 1997 and the Iwai Memorial Lecture in Yokohama, Japan, 2016. Dr. Lerman has authored more than 120 peer-reviewed manuscripts (Hirsh Index >40) on a variety of subjects in pediatric anesthesia with emphasis on Inhalational anesthetics, edited/authored three textbooks (A Practice of Anesthesia for Infants and Children 6th Ed; Manual of Pediatric Anesthesia 7th Ed; and Neonatal Anesthesia 2nd Ed (2021)), 150 review articles, chapters and editorials and received 25 peer and non-peer-reviewed grants. He has delivered more than 300 lectures along with visiting professorships in over 30 countries. He holds 2 patents for a novel respiratory device and launched the Peds-Anesth app (with Drs. CJ Coté and B Anderson) in 2015.


The 2023 Hit Parade of New Drugs
Friday, February 3, 2023
7:10 PM - 7:35 PM
Most Influential Recent Pediatric Anesthesia Manuscripts
Saturday, February 4, 2023
10:50 AM - 11:10 AM

Disclosure Information

No financial relationships with commercial interests to disclose.